Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,152 | -6,938 | -11,404 | -6,733 | -3,293 |
| Depreciation Amortization | 566 | 313 | 9 | 6 | 3 |
| Income taxes - deferred | -627 | -12,722 | 0 | N/A | N/A |
| Accounts receivable | 125 | N/A | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,285 | 1,527 | 36 | 1,060 | 713 |
| Other Working Capital | -2,161 | 1,843 | 63 | -2,012 | 64 |
| Other Operating Activity | 4,323 | -174 | 412 | -856 | -607 |
| Operating Cash Flow | $-8,211 | $-16,151 | $-10,884 | $-8,535 | $-3,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -94 | -11 | -8 | -8 |
| Net Acquisitions | -12,294 | -30,994 | N/A | N/A | N/A |
| Purchase Of Investment | -1,200 | -5,169 | -2,955 | -1,479 | -735 |
| Sale Of Investment | 1,476 | 6,881 | 3,200 | 1,972 | 735 |
| Purchase Sale Intangibles | -657 | N/A | 0 | N/A | N/A |
| Other Investing Activity | -1,300 | 141 | 141 | 0 | 0 |
| Investing Cash Flow | $-13,385 | $-29,235 | $375 | $485 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 14,914 | 4,927 | 4,927 | 4,927 |
| Debt Repayment | -18,173 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 92,269 | 56,800 | 36,994 | 98 | 97 |
| Common Stock Repurchased | -76 | -6 | -5 | -5 | -5 |
| Other Financing Activity | -16,737 | 789 | 789 | 3,406 | 3,406 |
| Financing Cash Flow | $57,283 | $72,497 | $42,705 | $8,426 | $8,425 |
| Exchange Rate Effect | -28 | N/A | 0 | N/A | N/A |
| Beginning Cash Position | 41,084 | 13,973 | 13,973 | 13,973 | 13,973 |
| End Cash Position | 76,743 | 41,084 | 46,169 | 14,349 | 19,270 |
| Net Cash Flow | $35,659 | $27,111 | $32,196 | $376 | $5,297 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,211 | -16,151 | -10,884 | -8,535 | -3,120 |
| Capital Expenditure | -67 | -94 | -11 | -8 | -8 |
| Free Cash Flow | -8,278 | -16,245 | -10,895 | -8,543 | -3,128 |